Anupama Nandagudi

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Peter Nash, Bruce Kirkham, Masato Okada et al. · The Lancet · 2017 · 390 citations · Full text

Rheumatoid Disorder, Rheumatology, Spirit-p2 Phase 3 +12

Hydrothermal synthesis of transition metal oxides, transition metal oxide/carbonaceous material nanocomposites for supercapacitor applications

Anupama Nandagudi, M.S. Santosh, Basavanakote M. Basavaraja et al. · Materials Today Sustainability · 2022 · 179 citations

Materials Science, Chemical Engineering, Supercapacitors +10

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

F. David Carmona, Augusto Vaglio, Sarah Mackie et al. · The American Journal of Human Genetics · 2016 · 101 citations · Full text

Inflammation, Genome-wide Association Study, Vascular Disease +11

The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

Vibeke Strand, David Jayne, Audra Horomanski et al. · The Lancet Rheumatology · 2023 · 28 citations · Full text

Advocate Trial, Rheumatology, Autoimmune Disease +11

Mycoplasma pneumoniae infection associated with urticarial vasculitis mimicking adult-onset Still’s disease

J. Dua, Anupama Nandagudi, Nurhan Sutcliffe · Rheumatology International · 2011 · 20 citations · Full text

Autoimmune Disease, Vasculitis, Mycoplasma Pneumoniae Infection +7